Header Logo

Connection

Wansu Chen to Asthma

Back to Details
This is a "connection" page, showing publications Wansu Chen has written about Asthma.
Wansu Chen
Connection Strength
6.287
Asthma
  1. Neighborhood Deprivation and Crime on Asthma Exacerbations and Utilization in Mild Adult Asthma. J Allergy Clin Immunol Pract. 2024 Nov; 12(11):2966-2974.e11.
    View in: PubMed
    Score: 0.760
  2. Burden of Specialist-Diagnosed Chronic Cough in Adults. J Allergy Clin Immunol Pract. 2020 05; 8(5):1645-1657.e7.
    View in: PubMed
    Score: 0.556
  3. Controller therapy in Asians and whites with persistent Asthma. Asian Pac J Allergy Immunol. 2019 Jun; 37(2):73-86.
    View in: PubMed
    Score: 0.530
  4. Fractional Exhaled Nitric Oxide-Assisted Management of Uncontrolled Persistent Asthma: A Real-World Prospective Observational Study. Perm J. 2019; 23.
    View in: PubMed
    Score: 0.515
  5. Fatal Asthma: An Audit of 30 Million Patient-Years of Health Plan Membership from 2007 to 2015. J Allergy Clin Immunol Pract. 2019 02; 7(2):597-605.
    View in: PubMed
    Score: 0.504
  6. Real-time asthma outreach reduces excessive short-acting ß2-agonist use: a randomized study. J Allergy Clin Immunol Pract. 2014 Jul-Aug; 2(4):445-456, 456.e1-5.
    View in: PubMed
    Score: 0.372
  7. Development and preliminary validation of the Asthma Intensity Manifestations Score (AIMS) derived from Asthma Control Test, FEV(1), fractional exhaled nitric oxide, and step therapy assessments. J Asthma. 2012 Mar; 49(2):172-7.
    View in: PubMed
    Score: 0.319
  8. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol. 2011 Aug; 128(2):412-4.
    View in: PubMed
    Score: 0.308
  9. Association of exhaled nitric oxide to asthma burden in asthmatics on inhaled corticosteroids. J Asthma. 2011 Feb; 48(1):8-17.
    View in: PubMed
    Score: 0.295
  10. Step-up care improves impairment in uncontrolled asthma: an administrative data study. Am J Manag Care. 2010; 16(12):897-906.
    View in: PubMed
    Score: 0.276
  11. The HEDIS Medication Management for People with Asthma measure is not associated with improved asthma outcomes. J Allergy Clin Immunol Pract. 2019 04; 7(4):1327-1329.e8.
    View in: PubMed
    Score: 0.127
  12. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1050-1060.e9.
    View in: PubMed
    Score: 0.113
  13. Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):144-153.e8.
    View in: PubMed
    Score: 0.110
  14. Characteristics and Outcomes of HEDIS-Defined Asthma Patients with COPD Diagnostic Coding. J Allergy Clin Immunol Pract. 2016 Mar-Apr; 4(2):273-83.e5.
    View in: PubMed
    Score: 0.104
  15. Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting. J Allergy Clin Immunol Pract. 2016 Jan-Feb; 4(1):120-9.e3.
    View in: PubMed
    Score: 0.103
  16. Hypertension and Asthma: A Comorbid Relationship. J Allergy Clin Immunol Pract. 2016 Jan-Feb; 4(1):76-81.
    View in: PubMed
    Score: 0.102
  17. Adherent uncontrolled adult persistent asthma: Characteristics and asthma outcomes. J Allergy Clin Immunol Pract. 2015 Nov-Dec; 3(6):986-90.e2.
    View in: PubMed
    Score: 0.102
  18. Prospective Study on the Relationship of Obesity to Asthma Impairment and Risk. J Allergy Clin Immunol Pract. 2015 Jul-Aug; 3(4):560-5.e1.
    View in: PubMed
    Score: 0.100
  19. The association of blood eosinophil counts to future asthma exacerbations in children with persistent asthma. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):283-287.e4.
    View in: PubMed
    Score: 0.098
  20. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract. 2014 Nov-Dec; 2(6):741-50.
    View in: PubMed
    Score: 0.095
  21. Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2014 Jun; 133(6):1549-56.
    View in: PubMed
    Score: 0.091
  22. Change in asthma control over time: predictors and outcomes. J Allergy Clin Immunol Pract. 2014 Jan-Feb; 2(1):59-64.
    View in: PubMed
    Score: 0.090
  23. Overweight/obesity and risk of seasonal asthma exacerbations. J Allergy Clin Immunol Pract. 2013 Nov-Dec; 1(6):618-22.
    View in: PubMed
    Score: 0.089
  24. Development and preliminary validation of the Adult Asthma Adherence Questionnaire™. J Allergy Clin Immunol Pract. 2013 May-Jun; 1(3):280-8.
    View in: PubMed
    Score: 0.087
  25. The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations. Chest. 2012 Jan; 141(1):66-72.
    View in: PubMed
    Score: 0.077
  26. Further validation and definition of the psychometric properties of the Asthma Impact Survey. J Allergy Clin Immunol. 2011 Jul; 128(1):44-49.e1.
    View in: PubMed
    Score: 0.075
  27. Persistent asthma defined using HEDIS versus survey criteria. Am J Manag Care. 2010 Nov 01; 16(11):e281-8.
    View in: PubMed
    Score: 0.073
  28. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database. Am J Manag Care. 2010 May; 16(5):327-33.
    View in: PubMed
    Score: 0.071
  29. Effect of chorioamnionitis on early childhood asthma. Arch Pediatr Adolesc Med. 2010 Feb; 164(2):187-92.
    View in: PubMed
    Score: 0.069
  30. Asthma costs and utilization in a managed care organization. J Allergy Clin Immunol. 2008 Apr; 121(4):885-92.e5.
    View in: PubMed
    Score: 0.061
  31. The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol. 2008 Sep; 101(3):240-7.
    View in: PubMed
    Score: 0.016

© 2025 Kaiser Permanente